Klick Health Builds Out Global Leadership Team and Offices
10.11.2022 12:03:00 EET | Business Wire | Press release
Building on its recent news about taking the company global, Klick Health today made several senior, global leadership team announcements as it builds out regional hubs in Asia-Pacific (APAC); Europe, the Middle East, and Africa (EMEA); and Latin America (LATAM).
Klick Health CEO Lori Grant welcomed agency veterans Jennifer Lambert and Roberta Raduan as its first global Managing Directors, and accomplished operations professionals Michael Becker, Shaun Chalk, and Catherine MacInnis to help lead its global operations and growth. The new senior executives will build on Klick’s strong people-first business model and supporting foundations, and work alongside seasoned Klick leaders Glen Webster, who has been named Executive Vice President, Global Operations; and Jennifer White, Global Head of Growth.
“We couldn’t be happier to welcome Jen Lambert, Roberta, Shaun, Mike, and Catherine to Klick–they are all proven leaders in their fields and have the global expertise required for a successful global rollout,” said Grant. “We’re also thrilled to announce Glen’s and Jen White’s new global roles–they have both contributed immeasurably to our industry-leading success and will be instrumental in helping us scale the Klick magic overseas.”
Jennifer Lambert – Managing Director, EMEA
A proven leader in growing agencies, managing client relations, and launching campaigns across the globe, Lambert joins Klick as Managing Director of EMEA. She spent the last decade at WPP, most recently as Chief Health Officer at Wunderman Thompson Health International, with many years serving as WPP lead for Team Pfizer, overseeing all the operations and talent across EMEA for the large network agency. Prior, she spent 15 years at Sudler & Hennessey, growing the agency’s presence across EMEA and Asia-Pacific. Lambert began her career at Ogilvy in New York after earning a biomedical degree at Rutgers University. She has worked across the spectrum of all therapeutic areas and has extensive expertise internationally within CRM, DTC, omnichannel, and brand defense/LTV strategy planning. Outside of work, Jennifer donates her time to helping create change in health, including working on pro-bono platforms with the United Nations, NGOs, and academia to help drive support for victims of sexual abuse and violence.
“I joined Klick because there is something really different here,” Lambert said. “I love the entrepreneurial spirit and incredible energy you get from a large, independent powerhouse like Klick, and I’m thrilled to be helping bring Klick’s end-to-end services to life sciences clients in Europe, the Middle East, and Africa and creating real healthcare change across the globe.”
Roberta “Beta” Raduan – Managing Director, LATAM
Based out of São Paulo, Brazil, Raduan brings to Klick her proven entrepreneurial track record building successful agencies and her long-standing relationships with both clients and top talent in Latin America. A digital native and seasoned marketing communications professional with a strategic understanding of brands and business opportunities in the digital, data, and communication arenas, Raduan has spent the last 25+ years helping global and local B2B, CPG, fintech, FMCG, and telco brands achieve transformational growth. Most recently, she was Managing Director of Havas CX Brasil, previously serving as Digital Managing Director of Havas Brasil. Raduan was also a co-founding Partner and Managing Director of several São Paulo agencies, including Versão Beta, Sinc, and Euro RSCG 4D (Havas).
“I am thrilled about launching Klick in Latin America and bringing its award-winning, people-first approach here,” said Raduan. “I was drawn to Klick’s unique culture and its obsession for identifying and hiring top talent. Klick’s commitment to keep evolving to exceed clients’ needs and make the world a better, healthier place really resonates with my heart and soul.”
Michael Becker – Chief Financial Officer, Klick Group
Becker joins as Klick Group CFO with invaluable global finance leadership in the life sciences industry. Formerly a Senior Vice President at Pharmaceutical Product Development (PPD), he led a team of more than 450 global finance professionals. During his tenure at the industry-leading contract research organisation, Becker played a primary role in a number of its key strategic initiatives, Becker previously served as PPD’s Executive Director of Operations and Executive Director of Internal Audit. Prior, he spent 12 years in public accounting at Deloitte & Touche, mainly in external audit roles.
“I’m very excited to join Klick Group as CFO and serve as a strategic business partner to its forward-thinking, world-class leaders,” Becker said. “What the Klick team has done over the past 25 years is truly remarkable and a testament to the culture of excellence here. I look forward to helping build on Klick’s existing strong foundations as we scale the business further to support our people, our clients, and the patients they serve.”
Shaun Chalk – Executive Vice President, Global Client Operations
Chalk joins Klick in the newly minted role of EVP of Global Client Operations, focused on enhancing strategic value to clients and creating compelling commercial narratives across the organisation, as it scales internationally. He brings 25+ years of marketing & communication, commercial, finance and operational experience to the role–the last eight years at WPP, most recently as Chief Commercial Officer at WPP Health & Wellness. Previously, he was Global CFO for McCann Worldgroup’s Commonwealth and a Director of Global Operations & Technology at Citigroup. He spent his early career at Wunderman, Y&R, and Ogilvy, where he worked in senior finance and commercial positions in both U.S. and worldwide groups. Chalk has an MBA and Accounting and Economics degrees.
“This is a very exciting time to be joining Klick, with the opportunity to contribute to its continued growth and success as it continues to expand globally,” said Chalk. “I look forward to embracing the Klickster culture, partnering with our teams to deliver on our clients’ goals and objectives, and ultimately helping to improve health outcomes for more patients around the world.”
Catherine MacInnis – General Counsel
As General Counsel, MacInnis is responsible for Klick’s risk and legal portfolio worldwide, with a focus on growth, compliance, insurance, and corporate governance. She leads all legal aspects of the company’s global expansion, including strategic decision-making, as well as all corporate/commercial, employment, immigration, and privacy matters related to the expansion. She has contributed to the annual World Bank report on business regulation (Doing Business) and presents frequently on risk management for professional services providers. Prior to joining Klick, MacInnis served as Associate General Counsel at publicly traded, design-driven technology firm IBI Group from its global headquarters in Toronto. There, she was key in managing the growth of its award-winning legal team as the company quickly scaled to 3,300 people with offices around the world. Earlier in her career, she spent four years in Commercial Litigation at Blaney McMurtry LLP, and three years as a securities & commercial litigator at Groia & Company.
MacInnis said, “I joined Klick because I have the phenomenal opportunity to work with Klick’s industry thought leaders on very cool projects, including global expansion, and I could not be more excited to help make the vision of our incredible team a reality.”
Glen Webster, Executive Vice President, Global Operations
For almost two decades, Webster has played a pivotal role in laying the strong foundation for Klick’s award-winning workplace culture and industry-leading business performance. He has consistently helped inoculate Klick against the status quo and think differently–establishing and piloting many internal operational capabilities over the years, including in-house Culture & Engagement, Recruiting, Marketing, Contracts, Tax, Strategic Alliances, and Performance Management, eventually evolving them into departments run by others. Webster began his career 30 years ago in management consulting, working at Deloitte Consulting, CGI, and Price Waterhouse, and serving a diverse set of clients, including Astra Pharma, Bank of Montreal, and Sony. He has strong entrepreneurial roots, started Canada's first online retail drugstore during the dot-com boom (and winding it up during the bust), and selling enterprise software to clients, like Goldman Sachs. He has also served as a part-time professor, teaching at post-secondary institutions, such as the MBA program at the Schulich School of Business at York University, before finally joining Klick in 2006.
“I’ve spent more than half of my career focused on Klick’s growth and am incredibly energised about helping lead the charge in this exciting new chapter of our company’s history,” said Webster. “Going global means access to brilliant new talent markets and making more client wishes come true as we share the Klick difference with the whole world!”
Jennifer White, Global Head of Growth
White has spent over 20 years working across multiple healthcare industry segments in the U.S. and abroad, most recently as an Executive Vice President of Growth at Klick. With her deep understanding of every facet of the commercialisation lifecycle of healthcare clients, White will continue to drive the operationalisation and scaling of Klick’s growth efforts in North America in her new role as Global Head of Growth. She will also help commercialise Klick’s new global marketing model for the life sciences industry, which is designed to drive efficiency and scalability of marketing initiatives around the world, and leverages the full suite of assets within the Klick ecosystem to provide an agile and insights-driven global marketing approach, while synergistically incorporating critical local and regional nuances. Prior to Klick, White served as the founding Chief Commercial Officer for Circulation, where she led the company’s commercial efforts from their pre-revenue phase through the close of their $10.5 million Series A round. Earlier in her career, she held executive leadership roles at both WebMD and Aptus Health.
“I am incredibly grateful to have the opportunity to heighten my work in healthcare and growth to help drive commercial success for Klick’s new global model,” White said. “I’m also excited about the plans our team has to disrupt and transform antiquated global marketing approaches with a forward-thinking, agile model that honors the unique needs of local markets, while creating global campaigns in an efficient and scalable manner.”
According to Klick Co-President Ari Schaefer, “We’re delighted with how our global expansion is developing and by the response we’ve been getting around the world. This is just the beginning–we will have more exciting news to share in the near future.”
About Klick Health
Klick Health is the world’s largest independent commercialisation partner for life sciences. For over 25 years, Klick has been laser-focused on developing, launching, and supporting life sciences brands to maximise their full market potential as a core commercialisation partner. Klick recently ranked #1 on Medical Marketing + Media (MM+M) magazine’s Agency 100 list for the fifth straight year and was named an MM+M Large Agency of the Year for both 2020 and 2021, marking 10 Agency of the Year industry awards in 11 years. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.
About Klick Group
The Klick Group of companies–Klick Health (including Klick Katalyst), Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs–is an ecosystem of brilliant talent collectively working to maximise their people’s and clients’ full potential. Established in 1997, Klick has teams across North America, with offices in New York, Philadelphia, and Toronto, and is opening global offices in Basel, Buenos Aires, London, Munich, Paris, Singapore, São Paulo, and Tokyo. Klick has consistently been named a Best Managed Company and Great Place to Work. In 2021, the company was recognised with 15 Best Workplace awards, including Best Workplaces for Women, Best Workplaces for Inclusion, Best Workplaces for Giving Back, Fast Company’s Best Workplaces for Innovators, and FORTUNE’s Best Workplaces for Millennials.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027006033/en/
Contact information
Sheryl Steinberg, Senior Vice President, Communications
416-214-4977 ext. 2412 pr@klick.com
Marisa McWilliams, Senior Manager, Communications
862-335-8165 pr@klick.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
